Tamil Nadu govt gives consent to BCG trial at ICMR's Chennai institute

Chennai, Tamil Nadu Published: Jul 15, 2020, 02:35 PM(IST)

Representative image of testing vial Photograph:( Reuters )

Story highlights

The NIRT under the ICMR is an internationally recognised institution for TB research

Sanction has been accorded to a trial by the Indian Council of Medical Research's Tuberculosis institute here to study the efficacy of BCG vaccine in the elderly in the fight against COVID-19, the government said on Wednesday.

Chief Minister K Palaniswami, in an order, has given the State's approval after ICMR sought Tamil Nadu government's permission to study the efficacy of the Bacillus Calmette- Gurin (BCG) vaccine in senior citizens at its National Institute for Research in Tuberculosis (NIRT) at Chetpet here,Health Minister C Vijayabaskar said.

Also read: India's Zydus begins human trials for potential COVID-19 vaccine

"The ICMR's tuberculosis institute is set to begin the trial very soon," he said in a statement.

He hoped that vaccinating the elderly with the time tested BCG would help reduce the intensity of COVID-19, admissions at hospitals and mortality rates.

Also read: Covid-19 cases in India rise to 9.3 lakh, death toll at 24,309

Describing the state's approval by Palaniswami for a trial here as among measures to protect people's welfare during the ongoing fight against COVID-19, Vijayabaskar said anti-viral measures will further be stepped up.

The NIRT under the ICMR is an internationally recognised institution for TB research.

Read in App